Translation of recent biological discoveries into clinical applications has been plagued by "long timelines, steep costs, and high failure rates," writes National Institutes of Health Director Francis Collins in a commentary in Science Translational Medicine.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.